Previous Article | Next Article 
Molecular and Cellular Biology, March 2002, p. 1488-1494, Vol. 22, No. 5
0270-7306/02/$04.00+0 DOI: 10.1128/MCB.22.5.1488-1494.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Embryonic Lethality Caused by Apoptosis during Gastrulation in Mice Lacking the Gene of the ADP-Ribosylation Factor-Related Protein 1
A. G. Mueller,1 M. Moser,2 R. Kluge,3 S. Leder,1 M. Blum,4 R. Büttner,2 H.-G. Joost,1 and A. Schürmann1*
Institute of Pharmacology,1
Institute of Pathology,2
Institute of Animal Research, Medical Faculty, Technical University of Aachen, D-52057 Aachen,3
Institute of Toxicology and Genetics, Forschungszentrum Karlsruhe, D-76021 Karlsruhe, Germany4
Received 4 October 2001/
Returned for modification 27 November 2001/
Accepted 6 December 2001

ABSTRACT
ADP-ribosylation factor (ARF)-related protein 1 (ARFRP1) is
a membrane-associated GTPase with significant similarity to
the family of ARFs. We have recently shown that ARFRP1 interacts
with the Sec7 domain of the ARF-specific guanine nucleotide
exchange factor Sec7-1/cytohesin and inhibits the ARF/Sec7-dependent
activation of phospholipase D in a GTP-dependent manner. In
order to further analyze the function of ARFRP1, we cloned the
mouse
Arfrp1 gene and generated
Arfrp1 null-mutant mice by gene
targeting in embryonic stem cells. Heterozygous
Arfrp1 mutants
developed normally, whereas homozygosity for the mutant allele
led to embryonic lethality. Cultured homozygous
Arfrp1 null-mutant
blastocysts were indistinguishable from wild-type blastocysts.
In vivo, they implanted and formed egg cylinder stage embryos
that appeared normal until day 5. Between embryonic days 6 and
7, however, apoptotic cell death of epiblast cells occurred
in the embryonic ectoderm during gastrulation, as was shown
by histological analysis combined with terminal deoxynucleotidyltransferase-mediated
dUTP-biotin nick end labeling. Epiblast cells that would normally
differentiate to mesodermal cells detached from the ectodermal
cell layer and were dispersed into the proamniotic cavity. In
contrast, the development of extraembryonic structures appeared
unaffected. Our results demonstrate that ARFRP1 is necessary
for early embryonic development during gastrulation.

INTRODUCTION
ADP-ribosylation factors (ARFs) are GTP-binding proteins that
are involved in multiple steps of membrane trafficking and regulation
of phospholipase D (PLD) (
5,
15,
20,
24,
29). ARFRP1 (ARF-related
protein 1), previously designated ARP (
25), is a membrane-associated
25-kDa GTPase with remote similarity to ARF and ARF-like protein
(33 and 39% identical amino acids to ARF1 and ARF-like 3, respectively).
ARFRP1 contains all characteristic sequence motifs involved
in nucleotide binding and GTP hydrolysis. Compared with other
GTPases, guanine nucleotide exchange of recombinant ARFRP1 is
slow but GTPase activity is high in the absence of an activating
protein. In contrast to ARF and ARF-like proteins, ARFRP1 lacks
the N-terminal myristoylation motif (glycine 2) necessary for
membrane association. However, ARFRP1 is predominantly located
in the plasma membrane and is absent from the cytosol (
25),
whereas ARF proteins shuttle between membranes and the cytosol,
depending on the bound nucleotide (
3). Previous studies have
suggested that ARFRP1 is involved in a pathway inhibiting the
ARF-controlled activity of PLD (
26). ARFRP1 binds the ARF-specific
nucleotide exchange factor Sec7-1/cytohesin in a GTP-dependent
manner and inhibits the ARF/Sec7-dependent activation of PLD.
In addition, transfection of HEK-293 cells with a constitutively
active mutant of ARFRP1 inhibited the PLD stimulation induced
by muscarinic acetylcholine receptor-3 and the translocation
of ARF from the cytosol to membranes.
ARF and ARF-like proteins are highly conserved throughout the evolution of eukaryotes (29). In yeast, five members of the ARF-family have been identified (9, 14, 21, 22). The closest relative of ARFRP1 is yARF-like protein 3 (yARL3), with 43% identical amino acids (14). Disruption of the yArl3 gene resulted in enhanced cold sensitivity of growth and in retarded processing of alkaline phosphatase and carboxypeptidase Y at the nonpermissive temperature. Thus, it was suggested that yARL3 is involved in protein transport between endoplasmic reticulum, Golgi, and vacuole (14).
In order to characterize the function of ARFRP1 in a mammalian organism, we generated mice with a targeted disruption of the Arfrp1 gene. It is shown here that homozygosity for the transgene causes embryonic lethality at gastrulation and apoptosis of ectodermal cells that would normally differentiate and form the mesodermal cell layer.

MATERIALS AND METHODS
Library screening and DNA sequencing.
Genomic clones of
Arfrp1 were isolated by screening a 129 SvJ
mouse genomic library (Lambda FIX II Vector; Stratagene, La
Jolla, Calif.) with a cDNA probe derived from the rat ARFRP1
cDNA. Two clones were isolated and sequenced after fragmentation
by sonication or digestion with restriction enzymes and subcloning
into pUC18 and pGEM-5Zf(+). Sequencing was performed in both
directions (Thermo-sequenase fluorescent-labeled primer cycle
sequencing kit; Amersham Life Science, Little Chalfont, Bucks,
United Kingdom) with the aid of an automated sequencer (LI-COR,
Lincoln, Neb.).
Gene targeting.
For generation of the targeting vector, a 5.6-kb clone in pGEM-5Zf(+) was used. The 595 bp containing exons 2 and 3, encoding the start codon, the PM1-PM3, and the G1 motifs, was replaced by a 1.1-kb neomycin resistance cassette introducing a diagnostic StuI site. The targeting vector was linearized with NotI, and embryonic stem (ES) cells (129 SvJ) were transfected by electroporation. Cells were subsequently cultured in the presence of 400 µg of G418/ml for 12 days. A total of 288 neomycin-resistant ES clones were picked, and their genomic DNA was isolated and digested with StuI. For the identification of homologous recombinants, Southern blots were performed with a 3' external probe generated with a PCR fragment containing intron 4 (primers, 5'-GCAAAAGGAACCTGGAACTG-3" and 5"-CTGAAAGTGCTCAACTCAGG-3"). Two ES cell clones that had incorporated the targeting vector by homologous recombination were injected into C57Bl/6J blastocysts and subsequently were transferred into a pseudopregnant foster mouse. Male chimeric mice were mated with C57Bl/6J females. Genomic DNA was isolated from tail biopsies, digested with StuI, and analyzed by Southern blotting with the 3" external probe or by PCR with primers for amplification of both the Arfrp1 and the neo gene (primer 1 [ARFRP1, 200 bp], 5"-GGTCCACAACCCAGCTGAC-3"; primer 2 [Neo, 440 bp], 5"-CGAGGATCTCGTCGTGCCC-3"; primer 3 [ARFRP1 reverse], 5"-CCCAAAACATGAGACGAGCCTTCC-3").
Northern blot analysis.
RNA was prepared from liver, kidney, and testis as described previously (4). Samples (15 µg) of total RNA were separated by electrophoresis on 1% (wt/vol) agarose gels containing 3% (vol/vol) formaldehyde and were transferred onto nylon membranes (Hybond N+; Amersham-Pharmacia, Freiburg, Germany). Probes of the cDNA of rat ARFRP1 were generated with the Klenow fragment of DNA polymerase I and [
-32P]dCTP by random oligonucleotide priming. The nylon membranes were hybridized at 42°C, and blots were washed twice with 0.8% SSC (1x SSC is 0.15 M NaCl plus 0.015 M sodium citrate) containing 0.1% sodium dodecyl sulfate.
Immunochemical detection of ARFRP1 in membranes from different tissues.
Tissues (liver, kidney, and testis) were homogenized and centrifuged for 10 min at 600 x g. The supernatant was centrifuged at 200,000 x g at 4°C for 1 h. Resuspended membrane proteins (20 µg) were separated by sodium dodecyl sulfate-14% polyacrylamide gel electrophoresis and were transferred onto nitrocellulose. Immunochemical detection was performed with a polyclonal antiserum against recombinant ARFRP1 (25). Bound immunoglobulin was detected with 125I-protein A.
In vitro culture of blastocysts.
Arfrp1+/- mice were intercrossed in a 12-h mating period. At embryonic day 3.5 (E3.5), blastocysts were flushed from the uteri of plugged females and were cultured individually as described previously (12). After a resting period of 2 days, photographs were taken every 24 h. After 6 to 8 days in culture, the genotypes of the blastocysts were determined by PCR.
Histological analysis.
Uteri from females plugged in a 12-h mating period were isolated at E5.5, 6.5, 7.5, and 8.5. Uteri were fixed in 4% paraformaldehyde, dehydrated, and embedded in paraffin. Serial sections (5 µm) were stained with hematoxylin and eosin.
Terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) assays.
Apoptotic cells were detected in paraffin sections of mouse embryos of E5.5 to 8.5 with the aid of a TdT-FragEL DNA fragmentation detection kit (Oncogene Research Products, Boston, Mass.) according to the manufacturer's protocol. Sections were counterstained with methyl green.

RESULTS
Targeted disruption of the Arfrp1 gene.
Two genomic clones (13.5 kb and about 21 kb) comprising the
total
Arfrp1 gene (accession number AJ413952) were isolated
from a 129 SvJ library. The targeting construct was generated
by exchange of exons 2 and 3, coding for the translation start
and the essential nucleotide binding motifs PM1-PM3 and G1,
for a neomycin resistance cassette. The construct (Fig.
1A)
contained
3,015 bp of the 5' flanking region and 1,963 bp of intron 4.
Transfection of ES cells with the targeting construct yielded
four homologous recombinants in 288 transformants. Homologous
recombination was ascertained by Southern blot analysis with
an external probe (Fig.
1B). Injection of recombinant ES cells
into blastocysts of C57BL/6 mice resulted in the generation
of chimeric mice that were mated with C57BL/6 mice. F
1 mice
carrying the transgene were interbred and yielded
Arfrp1+/+ and
Arfrp1+/- mice with a frequency of 1:1.9 but yielded no
Arfrp1-/- mutants out of 94 offspring (Fig.
1B). This result
indicates that homozygous disruption of
Arfrp1 results in embryonic
lethality.
ARFRP1 is expressed during embryonic development.
In order to determine the ARFRP1 expression during embryonic development, a Northern blot analysis was performed with embryos of different stages. Figure 2
illustrates the time course of ARFRP1 expression between 4.5 and 18.5 days post-coitum (p.c.). ARFRP1 mRNA was already detected during early embryogenesis at day 4.5 p.c., increased during gastrulation and neurulation (E7.5 and 8.5), and remained high throughout embryogenesis, except for a decline at late stages of gestation (E17.5 and 18.5).
Phenotype of heterozygous Arfrp1 mutants.
Mice heterozygous for the
Arfrp1 deletion were phenotypically
normal and showed no difference in the development of body weight
over a time course of 6 months (data not shown). There was no
difference in ARFRP1 mRNA (data not shown) and protein levels
in liver, kidney, and testis between wild-type mice and
Arfrp1+/- mutants (Fig.
3),
indicating that the deletion of one allele
did not reduce expression of ARFRP1.
Characterization of Arfrp1-/- blastocysts.
No viable
Arfrp1-/- neonates were identified when heterozygous
mice were intercrossed, indicating that homozygosity for the
Arfrp1 mutation causes embryonic lethality. To investigate the
growth of
Arfrp1 mutant embryos, blastocysts (E3.5) from heterozygous
matings were individually cultured in vitro, and outgrowth was
monitored for 6 to 8 days. At the end of the experiment, genotypes
of the blastocysts were determined by PCR (Fig.
4B).
Among 32
cultured blastocysts obtained from 4 litters,
Arfrp1+/+,
Arfrp1+/-,
and
Arfrp1-/- blastocysts were identified at a ratio of 12:16:4.
As is shown in Fig.
4A, the morphology of
Arfrp1-/- blastocysts
was indistinguishable from that of
Arfrp1+/+ and
Arfrp1+/- blastocysts,
with the trophoblast spreading out on the culture dish and a
proliferating inner cell mass on top. This result indicates
that
Arfrp1-/- blastocysts were generated and that disruption
of
Arfrp1 did not alter the growth of stem cells or the development
of the blastocysts.
Deletion of Arfrp1 results in embryonic lethality at the gastrulation stage (E6.5 to 7.5) and prevents differentiation of embryonic ectoderm.
In order to determine the time point of death of
Arfrp1-/- mutants,
a histological analysis of uteri from heterozygous intercrosses
was performed at different days of gestation. At E5.5 all embryos
appeared normal (Table
1).
At E6.5 to 8.5 about 25% of the embryos
exhibited striking abnormalities (Table
1). In whole-mount preparations
of embryos at E7.5, the egg cylinder of
Arfrp1-/- mutants was
markedly reduced in size, whereas the ectoplacental cone appeared
unaffected (Fig.
5A).
In contrast, wild-type and heterozygous
embryos were indistinguishable (Fig.
5A and
B).
Histological analysis of abnormal embryos revealed massive defects
before and during gastrulation (Fig.
6).
At E6.5, abnormal embryos
could be recognized by profound alteration of the distal part
of the egg cylinder. Rounded pyknotic cells were found within
this area of the egg cylinder in the proamniotic cavity, and
some of these were only loosely attached to the ectodermal cell
layer (Fig.
6A and
B, lower panels). In contrast, the proximal
extraembryonic part of the embryo appeared normal. In order
to determine whether the morphologically abnormal cells within
the proamniotic cavity were apoptotic, TUNEL assays were performed
with sections adjacent to those stained for histological examination.
This analysis demonstrated that the pyknotic epiblast cells
in the area of the primitive streak region were TUNEL positive
and therefore were apoptotic. In contrast, normal egg cylinder
stage embryos showed the typical organization with the outer
epithelial layer, the visceral endoderm, and an inner epithelial
sheet, the primitive ectoderm (Fig.
6A and
B, upper panels).
The proximal, extraembryonic endodermal cells are characterized
by a columnar morphology with apical vacuoles, whereas the distal,
embryonic endodermal cells have no vacuoles and show a squamous
appearance. The ectoderm reveals marked differences between
the embryonic and extraembryonic parts as well, with a much
thicker epithelial organization of the distal embryonic cells
(Fig.
6B, upper panel).
At E7.5, histological differences between control and mutant
embryos were even more pronounced. Sagittal sections exhibited
defects in the embryonic ectodermal cell layer and accumulation
of dead cells within the amniotic cavity (Fig.
6C, lower panels).
Transversal sections confirmed this observation and demonstrated
that the abnormal embryo was disorganized; ectoplacental and
exocoelomic cavities had not formed (Fig.
6D, lower panels).
In contrast, normal primitive streak stage embryos exhibited
well organized ectoderm, endoderm, and mesoderm and developed
the ectoplacental, exocoelomic, and amniotic cavities (Fig.
6C, upper panels). The transversal sections demonstrated that
the embryonic mesodermal layer was formed between the ectodermal
and endodermal layer on the primitive streak side in control
embryos (Fig.
6D, upper panels).

DISCUSSION
The present study demonstrates that ARFRP1 is essential for
embryonic development. Our data indicate that
Arfrp1-/- blastocysts
are generated and that
Arfrp1-/- embryos undergo uterine implantation,
induce uterine decidualization, and develop into egg cylinders.
The embryonic lethality of the
Arfrp1-/- mutants was specifically
associated with the inability of the egg cylinder to gastrulate
properly at E6.5 (Fig.
6). At this early stage of gastrulation,
morphogenetic movements, cell proliferation, and differentiation
convert the embryonic portion of the egg cylinder, the epiblast,
into the three germ layers: ectoderm, mesoderm, and endoderm.
Epiblast cells are recruited to a transient embryonic structure
called the primitive streak at the future posterior pole of
the embryo, thereby establishing the anterior-posterior axis
(
1,
30). At the primitive streak, epiblast cells undergo an
epithelial-to-mesenchymal transition, generating the mesoderm
and definitive endoderm;
Arfrp1-/- embryos are defective in
this process. The epithelial organization of the epiblast is
disturbed and no mesodermal cells form. Instead, apoptotic cells
accumulate in the proamniotic cavity. At this point we cannot
determine whether these cells consist of mesendodermal cells
which leave the primitive streak in the wrong direction, i.e.,
towards the dorsal side of the embryo, or whether they represent
dying epiblast cells prior to the epithelial-mesenchymal transition.
The targeted inactivation of two other genes, Rac-1 and ß-catenin, produced very similar phenotypes. Rac-1-deficient embryos exhibit apoptotic cells in the space between the embryonic ectoderm and endoderm at the primitive streak stage (28). Rac-1 is a member of the Rho family of GTPases which has been shown to promote the reorganization of filamentous actin into lamellipodia and membrane ruffles and to be involved in the establishment of cell adhesion structures (13). Moreover, Rac-1 has been implicated in the invasion and metastasis of lymphoma cells (17, 23).
Like Arfrp1-/- embryos, ß-catenin knockout embryos showed cells that detached from the embryonic ectodermal cell layer at E7.0 p.c. (11). ß-Catenin is known to regulate cell-cell adhesion via interaction with the cytoplasmic domain of E-cadherin and
-catenin (27). In addition, ß-catenin functions as a component in the Wnt signaling pathway, which is involved in the regulation of development, cellular proliferation, and differentiation (18).
The similar phenotypes of Rac-1-/-, ß-catenin-/-, and Arfrp1-/- embryos suggests that ARFRP1 might be involved in the alteration of the cytoskeleton required during gastrulation. Our previous data showing that ARFRP1 inhibits the ARF-regulated PLD activation appears consistent with this hypothesis (26). PLD hydrolyzes phosphatidyl choline to generate phosphatidic acid and choline in response to a variety of signals, hormones, neurotransmitters, and growth factors (7, 8). It has been found that agonist-induced PLD stimulation can provoke changes in cell morphology through cytoskeletal rearrangements. Lysophosphatidic acid (LPA)-induced PLD activation has been shown to increase the amount of F-actin leading to an activation of actin polymerization (10). In porcine aortic endothelial cells, PLD activation results in the formation of stress fibers (6). The reduction of endogenous PLD activity by expression of an inactive PLD mutant caused a selective loss of the stress fiber response of LPA (16). In addition, it has been shown that the cytoskeletal protein ß-actin inhibits PLD activity by direct binding, suggesting that the agonist-induced translocation of ARF to the membrane might activate the repressed activity of PLD by the actin cytoskeleton (22). Since ARFRP1 inhibits the ARF-stimulated PLD activation (26), one might speculate that a lack of ARFRP1 as a negative regulator of PLD results in alterations of the cytoskeleton.
Cell migration is an essential process in embryonic development and is thought to be integrin dependent (2). There is indirect, circumstantial evidence that ARFRP1 might be involved in the regulation of integrin-mediated cell matrix adhesion. Overexpression of cytohesin-1, a protein that interacts with ARFRP1 in a GTP-dependent manner (26), increases ß2-integrin-dependent binding of Jurkat cells to ICAM-1 (19). Thus, it is conceivable that the deletion of the Arfrp1 gene results in defects of integrin-mediated cell adhesion and that this defect results in the failure of dividing epiblast cells to integrate properly into the ectodermal cell layer.
In summary, we present evidence that targeted inactivation of Arfrp1 results in defective gastrulation, enhanced cell death within the embryonic ectoderm, and a defect in mesendoderm development. We speculate that ARFRP1 plays a critical role in cytoskeletal reorganization or adhesion-dependent morphogenetic processes.

ACKNOWLEDGMENTS
This work was supported by the Deutsche Forschungsgemeinschaft
(Schu 750/3-3).
We thank H.-G. Frank and A. Heerler for helpful discussions. The skillful technical assistance of Sandra Dahmen and Uta Zahn is gratefully acknowledged.

FOOTNOTES
* Institute of Pharmacology, Medical Faculty, Technical University of Aachen, D-52057 Aachen, Germany. Phone: 49-241-8089137. Fax: 49-241-8082433. E-mail:
aschuermann{at}post.klinikum.rwth-aachen.de.


REFERENCES
1
- Beddington, R. S., and E. J. Robertson. 1999. Axis development and early asymmetry in mammals. Cell 96:195-209.[CrossRef][Medline]
2
- Brakebusch, C., E. Hirsch, A. Potocnik, and R. Fassler. 1997. Genetic analysis of beta1 integrin function: confirmed, new and revised roles for a crucial family of cell adhesion molecules. J. Cell Sci. 110:2895-2904.[Abstract]
3
- Cavenagh, M. M., J. A. Whitney, K. Carroll, C. J. Zhang, A. L. Boman, A. G. Rosenwald, I. Mellman, and R. A. Kahn. 1996. Intracellular distribution of Arf proteins in mammalian cells. Arf6 is uniquely localized to the plasma membrane. J. Biol. Chem. 271:21767-21774.[Abstract/Free Full Text]
4
- Chirgwin, J. M., A. E. Przybyla, R. J. McDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.[CrossRef][Medline]
5
- Cosson, P., and F. Letourneur. 1997. Coatomer (COPI)-coated vesicles: role in intracellular transport and protein sorting. Curr. Opin. Cell Biol. 9:484-487.[CrossRef][Medline]
6
- Cross, M. J., S. Roberts, A. J. H. Ridley, M. N. Hodgkin, A. Stewart, L. Claesson-Welsh, and M. J. Wakelam. 1996. Stimulation of actin stress fiber formation mediated by activation of phospholipase D. Curr. Biol. 6:588-597.
7
- Exton, J. H. 1997. Phospholipase D: enzymology, mechanisms of regulation, and function. Physiol. Rev. 77:303-320.[Abstract/Free Full Text]
8
- Exton, J. H. 1997. New developments in phospholipase D. J. Biol. Chem. 272:15579-15582.
9
- Garcia-Ranea, J. A., and A. Valencia. 1998. Distribution and functional diversification of the ras superfamiliy in Saccharomyces cerevisiae. FEBS Lett. 434:219-225.[CrossRef][Medline]
10
- Ha, K. S., E. J. Yeo, and J. H. Exton. 1994. Lysophosphatidic acid activation of phosphatidylcholine-hydrolysing phospholipase D and actin polymerization by a pertussis toxin-sensitive mechanism. Biochem. J. 303:55-59.
11
- Haegel, H., L. Larue, M. Ohsugi, L. Fedorov, K. Herrenknecht, and R. Kemler. 1995. Lack of ß-catenin affects mouse development at gastrulation. Development 121:3529-3537.[Abstract]
12
- Hakem, R., J. L. de la Pompa, C. Sirard, R. Mo, M. Woo, A. Hakem, A. Wakeham, J. Potter, A. Reimair, F. Biellia, E. Firpo, C. C. Hui, J. Roberts, J. Rossant, and T. W. Mak. 1996. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85:1009-1023.[CrossRef][Medline]
13
- Hall, A. 1998. Rho GTPases and the actin cytoskeleton. Science 279:509-514.[Abstract/Free Full Text]
14
- Huang, C. F., L. M. Buu, W. L. Yu, and F. J. Lee. 1999. Characterization of a novel ADP-ribosylation factor-like protein (yARL3) in Saccharomyces cerevisiae. J. Biol. Chem. 274:3819-3827.[Abstract/Free Full Text]
15
- Kahn, R. A., T. Terui, and P. A. Randazzo. 1996. Effects of acid phospholipase D on ARF activities: potential roles in membrane traffic. J. Lipid Mediat. Cell. Signal. 14:209-214.[CrossRef][Medline]
16
- Kam, Y., and J. H. Exton. 2001. Phospholipase D activity is required for actin stress fiber formation in fibroblasts. Mol. Cell. Biol. 21:4055-4066.[Abstract/Free Full Text]
17
- Keely, P. J., J. K. Westwick, I. P. Whitehead, C. J. Der, and L. V. Parise. 1997. Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature 390:632-636.[CrossRef][Medline]
18
- Kikuchi, A. 2000. Regulation of beta-catenin signaling in the Wnt pathway. Biochem. Biophys. Res. Commun. 268:243-248.[CrossRef][Medline]
19
- Kolanus, W., W. Nagel, B. Schiller, L. Zeitlmann, S. Godar, H. Stockinger, and B. Seed. 1996. Alpha L beta 2 integrin/LFA-1 binding to ICAM-1 induced by cytohesin-1, a cytoplasmic regulatory molecule. Cell 86:233-242.[CrossRef][Medline]
20
- Lee, F. J., C. F. Huang, W. L. Yu, L. M. Buu, C. Y. Lin, M. C. Huang, J. Moss, and M. Vaughan. 1997. Characterization of an ADP-ribosylation factor-like 1 protein in Saccharomyces cerevisiae. J. Biol. Chem. 272:30998-31005.[Abstract/Free Full Text]
21
- Lee, F. J., L. A. Stevens, Y. L. Kao, J. Moss, and M. Vaughan. 1994. Characterization of a glucose-repressible ADP-ribosylation factor (ARF3) from Saccharomyces cerevisiae. J. Biol. Chem. 269:20931-20937.[Abstract/Free Full Text]
22
- Lee, S., J. B. Park, J. H. Kim, Y. Kim, J. H. Kim, K.-L. Shin, J. S. Lee, S. H. Ha, P.-G. Luh, and S. H. Ryu. 2001. Actin directly interacts with phospholipase D, inhibiting its activity. J. Biol. Chem. 276:28252-28260.[Abstract/Free Full Text]
23
- Michiels, F., G. G. Habets, J. C. Stam, R. A. van der Kammen, and J. G. Collard. 1995. A role for Rac in Tiam1-induced membrane ruffling and invasion. Nature 375:338-340.[CrossRef][Medline]
24
- Rothman, J. E. 1994. Mechanisms of intracellular protein transport. Nature 372:55-63.[CrossRef][Medline]
25
- Schürmann, A., S. Massmann, and H.-G. Joost. 1995. ARP is a plasma membrane-associated Ras-related GTPase with remote similarity to the family of ADP-ribosylation factors. J. Biol. Chem. 270:30657-30663.[Abstract/Free Full Text]
26
- Schürmann, A., M. Schmidt, M. Asmus, S. Bayer, F. Fliegert, S. Koling, S. Massmann, C. Schilf, M. C. Subauste, M. Voss, K. H. Jakobs, and H.-G. Joost. 1999. The ADP-ribosylation factor (ARF)-related GTPase ARF-related protein binds to the ARF-specific guanine nucleotide exchange factor cytohesin and inhibits the ARF-dependent activation of phospholipase D. J. Biol. Chem. 274:9744-9751.
27
- Steinberg, M. S., and P. M. McNutt. 1998. Cadherins and their connections: adhesion junctions have broader functions. Curr. Opin. Cell Biol. 11:554-560.
28
- Sugihara, K., N. Nakatsuji, K. Nakamura, K. Nakao, R. Hashimoto, H. Otani, H. Sakagami, H. Kondo, S. Nozawa, A. Aiba, and M. Katsuki. 1998. Rac1 is required for the formation of three germ layers during gastrulation. Oncogene 17:3427-3433.[CrossRef][Medline]
29
- Takai, Y., T. Sasaki, and T. Matozaki. 2001. Small GTP-binding proteins. Physiol. Rev. 81:153-208.[Abstract/Free Full Text]
30
- Tam, P. P. L., and R. R. Behringer. 1997. Mouse gastrulation: the formation of a mammalian body plan. Mech. Dev. 68:3-25.[CrossRef][Medline]
Molecular and Cellular Biology, March 2002, p. 1488-1494, Vol. 22, No. 5
0270-7306/02/$04.00+0 DOI: 10.1128/MCB.22.5.1488-1494.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Nishimoto-Morita, K., Shin, H.-W., Mitsuhashi, H., Kitamura, M., Zhang, Q., Johannes, L., Nakayama, K.
(2009). Differential Effects of Depletion of ARL1 and ARFRP1 on Membrane Trafficking between the trans-Golgi Network and Endosomes. J. Biol. Chem.
284: 10583-10592
[Abstract]
[Full Text]
-
Schmidt, S, Hommel, A, Gawlik, V, Augustin, R, Junicke, N, Florian, S, Richter, M, Walther, D J, Montag, D, Joost, H-G, Schurmann, A
(2009). Essential role of glucose transporter GLUT3 for post-implantation embryonic development. J Endocrinol
200: 23-33
[Abstract]
[Full Text]
-
Zahn, C., Jaschke, A., Weiske, J., Hommel, A., Hesse, D., Augustin, R., Lu, L., Hong, W., Florian, S., Scheepers, A., Joost, H.-G., Huber, O., Schurmann, A.
(2008). ADP-ribosylation Factor-like GTPase ARFRP1 Is Required for Trans-Golgi to Plasma Membrane Trafficking of E-cadherin. J. Biol. Chem.
283: 27179-27188
[Abstract]
[Full Text]
-
Shin, H.-W., Kobayashi, H., Kitamura, M., Waguri, S., Suganuma, T., Uchiyama, Y., Nakayama, K.
(2005). Roles of ARFRP1 (ADP-ribosylation factor-related protein 1) in post-Golgi membrane trafficking. J. Cell Sci.
118: 4039-4048
[Abstract]
[Full Text]
-
LI, Y., KELLY, W. G., LOGSDON, J. M. JR, SCHURKO, A. M., HARFE, B. D., HILL-HARFE, K. L., KAHN, R. A.
(2004). Functional genomic analysis of the ADP-ribosylation factor family of GTPases: phylogeny among diverse eukaryotes and function in C. elegans. FASEB J.
18: 1834-1850
[Abstract]
[Full Text]
-
Adhikary, S., Peukert, K., Karsunky, H., Beuger, V., Lutz, W., Elsasser, H.-P., Moroy, T., Eilers, M.
(2003). Miz1 Is Required for Early Embryonic Development during Gastrulation. Mol. Cell. Biol.
23: 7648-7657
[Abstract]
[Full Text]